Transactions in Connection with Share Buy-back Program [Yahoo! Finance]
Genmab A/S - American Depositary Shares (GMAB)
Company Research
Source: Yahoo! Finance
The share buy-back program is expected to be completed no later than December 16, 2024. The following transactions were executed under the program from March 18, 2024 to March 22, 2024: Trading Platform No. of shares Average price (DKK) Total value (DKK) March 18, 2024 XCSE CEUX AQEU TQEX Total March 19, 2024 XCSE CEUX AQEU TQEX Total March 20 XCSE CEUX AQEU TQEX Total March 21, 2024 XCSE CEUX AQEU TQEX Total March 22, 2024 XCSE CEUX AQEU TQEX Total Accumulated under the program Details of each transaction are included as an appendix to this announcement. Following these transactions, Genmab holds 941,528 shares as treasury shares, corresponding to 1.42% of the total share capital and voting rights. The share buy-back program is undertaken in accordance with Regulation (EU) No. 596/2014 (‘MAR') and the Commission Delegated Regulation (EU) 2016/1052, also referred to as the “Safe Harbour Regulation.” Further
Show less
Read more
Impact Snapshot
Event Time:
GMAB
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
GMAB alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
GMAB alerts
High impacting Genmab A/S - American Depositary Shares news events
Weekly update
A roundup of the hottest topics
GMAB
News
- Cancer-Drug Maker Janux Therapeutics Weighs Possible Sale [BNN Bloomberg (Canada)]BNN Bloomberg
- Week In Review: ProfoundBio, A Seattle-Suzhou ADC Biotech, Acquired By Genmab For $1.8 Billion [Seeking Alpha]Seeking Alpha
- Genmab A/S (NASDAQ: GMAB) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $50.00 price target on the stock.MarketBeat
- Genmab to purchase US-based biotech company ProfoundBio for $1.8 billion in all-cash deal [Seeking Alpha]Seeking Alpha
- Denmark's Genmab to acquire ProfoundBio for $1.8 billion [Reuters]Reuters